Publications by the researcher in collaboration with David Otaegui Bichot (38)

2024

  1. Bacteria–Fungi Interactions in Multiple Sclerosis

    Microorganisms, Vol. 12, Núm. 5

2020

  1. The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis

    Cells, Vol. 9, Núm. 1

2019

  1. T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians

    Aging, Vol. 11, Núm. 22, pp. 10723-10741

2018

  1. Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old

    Frontiers in Aging Neuroscience, Vol. 10

  2. Expression profiling analysis reveals key Microrna-mRNA interactions in early retinal degeneration in retinitis pigmentosa

    Investigative Ophthalmology and Visual Science, Vol. 59, Núm. 6, pp. 2381-2392

2017

  1. Progressive changes in non-coding RNA profile in leucocytes with age

    Aging, Vol. 9, Núm. 4, pp. 1202-1218

2016

  1. Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation

    Neurology, Vol. 87, Núm. 12, pp. 1250-1257

  2. SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent

    Scientific Reports, Vol. 6

2015

  1. A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis

    Human Molecular Genetics, Vol. 24, Núm. 19, pp. 5619-5627

  2. Age gene expression and coexpression progressive signatures in peripheral blood leukocytes

    Experimental Gerontology, Vol. 72, pp. 50-56

  3. Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis

    BMC Genomics, Vol. 16, Núm. 1

  4. Neurogenetic Disorders in the Basque Population

    Annals of Human Genetics, Vol. 79, Núm. 1, pp. 57-75

2014

  1. Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients

    Multiple Sclerosis Journal, Vol. 20, Núm. 14, pp. 1851-1859

  2. Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis

    Biomarkers in Medicine, Vol. 8, Núm. 5, pp. 653-661

  3. Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression

    PLoS ONE, Vol. 9, Núm. 2

2012

  1. Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis

    Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 983-990

  2. HLA-DRB1*15:01 and multiple sclerosis: A female association?

    Multiple Sclerosis Journal, Vol. 18, Núm. 5, pp. 569-577

2010

  1. Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1

    Psychological Medicine, Vol. 40, Núm. 3, pp. 487-495

  2. Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain)

    Movement Disorders, Vol. 25, Núm. 14, pp. 2340-2345

  3. Somatic mosaicism in a case of apparently sporadic Creutzfeldt-Jakob disease carrying a de novo D178N mutation in the PRNP gene

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 153, Núm. 7, pp. 1283-1291